2028 年亚太地区心脏微导管市场预测 - COVID-19 影响和区域分析 - 按适应症(一般外周血管和冠状动脉)和最终用户(医院、专科诊所和门诊手术中心)

Historic Data: 2021-2022   |   Base Year: 2023   |   Forecast Period: 2024-2028


No. of Pages: 116    |    Report Code: BMIRE00028749    |    Category: Life Sciences

Asia Pacific Cardiac Microcatheter Market

亚太心脏微导管市场预计将从2023年的8047万美元增长到2028年的1.1476亿美元。预计2023年至2028年复合年增长率为7.4%。   

心脏微导管领域的新产品批准、发布和认知度激增,推动亚太心脏微导管市场

作为一种冠状动脉介入工具,微导管通过在复杂的血管解剖结构中实现广泛的功能来支持侵入性血管内手术的执行。世界各地的制造商都在投资先进技术的研发,这导致了新的和先进产品的开发,以及产品批准的激增。下面列出了一些产品的批准和开发; 2019年,iVasulous公司的新型冠状动脉微导管Navitian获得CE标志批准。该设备被批准用于在进入冠状动脉系统、交换导丝以及注射不透射线造影剂或盐溶液时促进、引导和支撑导丝。 2020 年,Bracco 集团公司 Acist Medical Systems Inc. 宣布在全球推出 Acist Navvus II 快速交换分数血流储备 (FFR) 微导管,这是与其 Acist RXi 快速交换 FFR 系统配合使用的第二代微导管。 FFR 测量可评估动脉病变的严重程度以及诊断和治疗冠状动脉疾病的干预策略。 2023 年 5 月,Acotec Scientific Holdings Ltd. 的微导管 Vericor-14 获得中国上市许可,用于辅助经皮冠状动脉介入治疗和经皮外周介入治疗,在竞争激烈的市场中领先一步,该市场有望在本世纪末增长八倍

因此,心脏微导管领域新产品的批准、发布和认知度的激增预计将推动预测期内心脏微导管市场的增长。

span>

亚太心脏微导管市场概览

亚太心脏微导管市场细分为中国、日本、印度、澳大利亚、韩国和亚太地区其他地区。该地区在亚太心脏微导管市场中占据重要地位,预计在预测期内将呈现出有希望的增长轨迹。市场增长的驱动因素是心血管疾病患病率上升、人口老龄化、医疗基础设施改善以及微创手术意识不断提高。

 到 2028 年亚太心脏微导管市场收入及预测(百万美元)

亚太地区心脏微导管市场细分

亚太地区心脏微导管市场分为适应症、最终用户和国家。

根据适应症,亚太心脏微导管市场分为一般外周血管和冠状动脉。 2023年,冠状动脉细分市场在亚太心脏微导管市场中占据较大份额。

根据最终用户,亚太心脏微导管市场分为医院、专科医院和专科医院。诊所和门诊手术中心。 2023 年,医院细分市场在亚太心脏微导管市场中占据最大份额。

按国家/地区划分,亚太心脏微导管市场分为中国、日本、印度、澳大利亚、韩国和亚太其他地区。 2023年,中国在亚太心脏微导管市场份额中占据主导地位。

波士顿科学公司;整数控股公司;美敦力公司;梅里特医疗系统公司;尼普罗公司; OrbusNeich医疗集团控股有限公司;泰利福公司;泰尔茂公司;和 Tokai Medical Products Inc 是亚太心脏微导管市场的领先公司。   



Asia Pacific Cardiac Microcatheter Strategic Insights

Strategic insights for Asia Pacific Cardiac Microcatheter involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/asia-pacific-cardiac-microcatheter-market-strategic-framework.webp
Get more information on this report

Asia Pacific Cardiac Microcatheter Report Scope

Report Attribute Details
Market size in 2023 US$ 80.47 Million
Market Size by 2028 US$ 114.76 Million
Global CAGR (2023 - 2028) 7.4%
Historical Data 2021-2022
Forecast period 2024-2028
Segments Covered By 适应症
  • 一般外周血管及冠状动脉
By 最终用户
  • 医院
  • 专科诊所
  • 门诊手术中心
Regions and Countries Covered 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
Market leaders and key company profiles
  • Boston Scientific Corp
  • Integer Holdings Corp
  • Medtronic Plc
  • Merit Medical Systems Inc
  • Nipro Corp
  • OrbusNeich Medical Group Holdings Ltd
  • Teleflex Inc
  • Terumo Corp
  • Tokai Medical Products Inc
  • Get more information on this report

    Asia Pacific Cardiac Microcatheter Regional Insights

    The regional scope of Asia Pacific Cardiac Microcatheter refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/asia-pacific-cardiac-microcatheter-market-geography.webp
    Get more information on this report

    The List of Companies - Asia Pacific Cardiac Microcatheter Market

    1. Boston Scientific Corp
    2. Integer Holdings Corp
    3. Medtronic Plc
    4. Merit Medical Systems Inc
    5. Nipro Corp
    6. OrbusNeich Medical Group Holdings Ltd
    7. Teleflex Inc
    8. Terumo Corp
    9. Tokai Medical Products Inc
    Frequently Asked Questions
    How big is the Asia Pacific Cardiac Microcatheter Market?

    The Asia Pacific Cardiac Microcatheter Market is valued at US$ 80.47 Million in 2023, it is projected to reach US$ 114.76 Million by 2028.

    What is the CAGR for Asia Pacific Cardiac Microcatheter Market by (2023 - 2028)?

    As per our report Asia Pacific Cardiac Microcatheter Market, the market size is valued at US$ 80.47 Million in 2023, projecting it to reach US$ 114.76 Million by 2028. This translates to a CAGR of approximately 7.4% during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Cardiac Microcatheter Market report typically cover these key segments-

  • 适应症 (一般外周血管及冠状动脉)
  • 最终用户 (医院, 专科诊所, 门诊手术中心)
  • What is the historic period, base year, and forecast period taken for Asia Pacific Cardiac Microcatheter Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Cardiac Microcatheter Market report:

  • Historic Period : 2021-2022
  • Base Year : 2023
  • Forecast Period : 2024-2028
  • Who are the major players in Asia Pacific Cardiac Microcatheter Market?

    The Asia Pacific Cardiac Microcatheter Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Boston Scientific Corp
  • Integer Holdings Corp
  • Medtronic Plc
  • Merit Medical Systems Inc
  • Nipro Corp
  • OrbusNeich Medical Group Holdings Ltd
  • Teleflex Inc
  • Terumo Corp
  • Tokai Medical Products Inc
  • Who should buy this report?

    The Asia Pacific Cardiac Microcatheter Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Cardiac Microcatheter Market value chain can benefit from the information contained in a comprehensive market report.